Oramed Pharmaceuticals Total Assets 2011-2019 | ORMP

Oramed Pharmaceuticals total assets from 2011 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Oramed Pharmaceuticals Annual Total Assets
(Millions of US $)
2018 $47
2017 $39
2016 $43
2015 $26
2014 $22
2013 $9
2012 $0
2012 $5
2011 $4
Oramed Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Q3 2019 $37
Q2 2019 $42
Q1 2018 $44
Q4 2018 $47
Q3 2018 $35
Q2 2018 $38
Q1 2017 $42
Q4 2017 $39
Q3 2017 $40
Q2 2017 $42
Q1 2016 $45
Q4 2016 $43
Q3 2016 $36
Q2 2016 $38
Q1 2015 $24
Q4 2015 $26
Q3 2015 $22
Q2 2015 $23
Q1 2014 $25
Q4 2014 $22
Q3 2014 $22
Q2 2014 $24
Q1 2013 $8
Q4 2013 $9
Q3 2013 $5
Q2 2013 $6
Q2 2012 $0
Q1 2012 $7
Q4 2012 $5
Q3 2012 $2
Q2 2012 $3
Q1 2011 $4
Q4 2011 $4
Q3 2011 $0
Q2 2011 $0
Q1 2010 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.065B $0.002B
Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $155.371B 29.26
Medtronic (MDT) Ireland $135.779B 19.40
Stryker (SYK) United States $77.789B 27.76
Boston Scientific (BSX) United States $59.103B 28.33
Baxter (BAX) United States $42.186B 26.59
EssilorLuxottica Societe Anonyme (ESLOY) France $29.208B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.885B 0.00
Coloplast (CLPBY) Denmark $25.726B 41.07
Zimmer Biomet Holdings (ZBH) United States $25.151B 16.16
Terumo (TRUMY) Japan $21.510B 24.73
Smith & Nephew SNATS (SNN) United Kingdom $19.003B 0.00
ResMed (RMD) United States $17.729B 33.87
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.051B 0.00
Bio-Rad Laboratories (BIO) United States $9.286B 49.23
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.213B 525.52
Perrigo (PRGO) Ireland $7.110B 12.02
Hill-Rom Holdings (HRC) United States $6.994B 21.20
Aurora Cannabis (ACB) Canada $6.825B 67.30
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.276B 51.23
ICU Medical (ICUI) United States $5.165B 30.82
GW Pharmaceuticals (GWPH) United Kingdom $4.920B 0.00
Neogen (NEOG) United States $3.306B 53.75
NuVasive (NUVA) United States $3.038B 24.81
Agios Pharmaceuticals (AGIO) United States $2.771B 0.00
Hutchison China MediTech (HCM) China $2.690B 0.00
National Vision Holdings (EYE) United States $2.444B 52.08
Quidel (QDEL) United States $2.233B 23.17
Cardiovascular Systems (CSII) United States $1.553B 891.80
Aphria (APHA) $1.549B 0.00
AtriCure (ATRC) United States $1.223B 0.00
Phibro Animal Health (PAHC) United States $1.210B 18.13
VAREX IMAGING (VREX) United States $1.182B 25.08
NanoString Technologies (NSTG) United States $1.115B 0.00
Lantheus Holdings (LNTH) United States $1.074B 28.53
PetIQ (PETQ) United States $1.006B 24.43
Quanterix (QTRX) United States $0.782B 0.00
Cerus (CERS) United States $0.777B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.34
Omeros (OMER) United States $0.714B 0.00
MacroGenics (MGNX) United States $0.707B 0.00
TG Therapeutics (TGTX) United States $0.667B 0.00
LeMaitre Vascular (LMAT) United States $0.620B 30.03
Surmodics (SRDX) United States $0.521B 75.80
OraSure Technologies (OSUR) United States $0.520B 23.94
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.515B 0.00
Meridian Bioscience (VIVO) United States $0.489B 14.96
BioLife Solutions (BLFS) United States $0.354B 110.71
Utah Medical Products (UTMD) United States $0.325B 22.51
Vapotherm (VAPO) United States $0.312B 0.00
Zynex (ZYXI) United States $0.255B 26.23
Cytosorbents (CTSO) United States $0.236B 0.00
Bovie Medical (APYX) United States $0.226B 0.00
Chimerix (CMRX) United States $0.185B 0.00
Rockwell Medical (RMTI) United States $0.171B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.155B 3.29
Fonar (FONR) United States $0.139B 7.31
Female Health (VERU) United States $0.135B 0.00
Chembio Diagnostics (CEMI) United States $0.105B 0.00
United-Guardian (UG) United States $0.093B 20.42
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.072B 0.00
MRI INTERVENTNS (MRIC) United States $0.053B 0.00
Trinity Biotech (TRIB) Ireland $0.051B 17.58
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.038B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00